BridgeMD
New treatment option for Social Anxiety Disorder
Official title School-based Treatment of Social Anxiety With Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder
ClinicalTrials.gov ID: NCT06489639
What this study is testing
- What it's testing
- The goal of this randomized controlled trial is to find out whether the brief, 10-session Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder (DOCT-SAD) is more effective than standard counseling (SC) to treat Social Anxiety Disorder (SAD) among 12 to 17-year-old adolescents with SAD. Potential participants for the study are identified from school health and well-being services (SHWS).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 17
You may be able to join if
- age 13-17 years
- diagnosis of DSM-5 SAD (Social Anxiety Disorder)
- SAD is the primary mental health disorder
- motivation of the adolescent and parent to attend DOCT-SAD / SC as described in the study protocol
- good command of the Finnish language.
You likely can't join if
- intellectual deficit
- presence of primary autism spectrum disorder
- marked psychotic symptoms or psyhotic disorder
- severe eating disorder, depression or primary other anxiety disorder requiring acute treatment which need to be prioritized above treatment of social...
- acute suicidality or suicide risk
- substance use or substance use disorder requiring child protection measures
See the full eligibility criteria
- age 13-17 years
- diagnosis of DSM-5 SAD (Social Anxiety Disorder)
- SAD is the primary mental health disorder
- motivation of the adolescent and parent to attend DOCT-SAD / SC as described in the study protocol
- good command of the Finnish language.
- intellectual deficit
- presence of primary autism spectrum disorder
- marked psychotic symptoms or psyhotic disorder
- severe eating disorder, depression or primary other anxiety disorder requiring acute treatment which need to be prioritized above treatment of social anxiety
- acute suicidality or suicide risk
- substance use or substance use disorder requiring child protection measures
- presence of contextual/environmental risk factors in the participants surroundings which require child protection measures
The study team makes the final eligibility decision.
Where it's taking place
- Tampere, Pirkanmaa, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tampere, Pirkanmaa, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.